Refine
Has Fulltext
- yes (7)
Is part of the Bibliography
- yes (7)
Document Type
- Journal article (7)
Language
- English (7)
Keywords
- hematopoietic stem cell transplantation (2)
- Ascaris lumbricoides (1)
- CMV (1)
- CMV-specific cellular immunity (1)
- IFN-γ ELISpot (1)
- MHC molecules (1)
- T cells (1)
- activating receptors (1)
- acute myelogenous leukemia (1)
- alternative to animal testing (1)
- antigen processing and presentation (1)
- cell therapy and immunotherapy (1)
- class-I (1)
- cytotoxicity receptors (1)
- donor-cell leukemia (1)
- graft-versus-host-disease (1)
- haematopoietic stem cell (1)
- immune monitoring (1)
- immunosuppression (1)
- immunotherapeutics (1)
- inflammation-induced tissue demage (1)
- inhibitory receptors (1)
- ligand incompatibility (1)
- mebendazole (1)
- missing self (1)
- multiple myeloma (1)
- mycophenolic acid (1)
- peptide (1)
- recall antigen (1)
- resting NK cells (1)
- sirolimus (1)
- skin equivalents (1)
- stem cell transplantation (1)
- tissue engineering (1)
- vascularization (1)
- virus-infected cells (1)
Institute
- Medizinische Klinik und Poliklinik II (7)
- Lehrstuhl für Tissue Engineering und Regenerative Medizin (2)
- Institut für Hygiene und Mikrobiologie (1)
- Klinik und Poliklinik für Allgemein-, Viszeral-, Gefäß- und Kinderchirurgie (Chirurgische Klinik I) (1)
- Klinik und Poliklinik für Dermatologie, Venerologie und Allergologie (1)
- Klinik und Poliklinik für Unfall-, Hand-, Plastische und Wiederherstellungschirurgie (Chirurgische Klinik II) (1)
- Pathologisches Institut (1)
Sonstige beteiligte Institutionen
Tissue-engineered skin equivalents mimic key aspects of the human skin, and can thus be employed as wound coverage for large skin defects or as in vitro test systems as an alternative to animal models. However, current skin equivalents lack a functional vasculature limiting clinical and research applications. This study demonstrates the generation of a vascularized skin equivalent with a perfused vascular network by combining a biological vascularized scaffold (BioVaSc) based on a decellularized segment of a porcine jejunum and a tailored bioreactor system. Briefly, the BioVaSc was seeded with human fibroblasts, keratinocytes, and human microvascular endothelial cells. After 14 days at the air-liquid interface, hematoxylin & eosin and immunohistological staining revealed a specific histological architecture representative of the human dermis and epidermis including a papillary-like architecture at the dermal-epidermal-junction. The formation of the skin barrier was measured non-destructively using impedance spectroscopy. Additionally, endothelial cells lined the walls of the formed vessels that could be perfused with a physiological volume flow. Due to the presence of a complex in-vivo-like vasculature, the here shown skin equivalent has the potential for skin grafting and represents a sophisticated in vitro model for dermatological research.